One of the reasons why chemotherapy treatments are difficult is because cancer cells are equipped with sophisticated defense mechanisms on their membranes that resist contact from anticancer drugs. Scientists at the Technion studied the complexities of this mechanism to develop a novel therapy strategy they calls the "Pharmacological Trojan Horse".